Insights into the cross‐talk between obesity and breast cancer development in BRCA mutation carriers may pave the way to improve proper personalized clinical management of BRCA1/2‐associated breast cancer. The gene discussed is BRCA1; the disease is obesity due to melanocortin 4 receptor deficiency.